This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Palau Pharma, S.A.

Drug Names(s): dersalazine sodium

Deal Structure: In September 2001, Indevus licensed exclusive, worldwide rights to dersalazine from Uriach, in exchange for an up-front licensing payment and potential development milestone and royalty payments to Uriach (Palau). In 2003, Indevus returned rights to Palau Pharma.

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug